|
Friday, December 6, 2024, San Diego, California, 11:30 AM – 1:30 PM PT (2:30 PM – 4:30 PM ET)
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of MyelofibrosisA CME Friday Satellite Symposium and Webcast Preceding the 66th ASH Annual Meeting
Program Schedule — Pacific Time
11:00 AM – 11:30 AM — Registration and Lunch 11:30 AM – 1:30 PM — Educational Meeting Location Manchester Grand Hyatt San Diego 1 Market Place San Diego, California Meeting Room Seaport E-H (Second Level) This event will also be webcast live. Please see Registration tab for details. Faculty
Prithviraj Bose, MD Professor, Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, Texas Angela G Fleischman, MD, PhD Associate Professor Department of Medicine Division of Hematology/Oncology UC Irvine Health Irvine, California Abdulraheem Yacoub, MD Professor of Medicine Division of Hematologic Malignancies and Cellular Therapeutics (HMCT) Department of Internal Medicine The University of Kansas Cancer Center Westwood, Kansas
Moderator
Andrew T Kuykendall, MD Associate Member Department of Malignant Hematology Moffitt Cancer Center Associate Professor Department of Oncologic Sciences University of South Florida Tampa, Florida This activity is supported by educational grants from CTI BioPharma, a Sobi Company, Geron Corporation, GSK, Incyte Corporation, and Karyopharm Therapeutics.
Program Schedule — Pacific Time
11:00 AM – 11:30 AM — Registration and Lunch 11:30 AM – 1:30 PM — Educational Meeting Discussion Topics
Target Audience
CE Credit FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Bose — Advisory Committees: Blueprint Medicines, Geron Corporation, Karyopharm Therapeutics, PharmaEssentia; Consulting Agreements: AbbVie Inc, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Disc Medicine, GSK, Incyte Corporation, Ionis Pharmaceuticals Inc, Jubilant Pharma Limited, Keros Therapeutics, Morphic Therapeutic, MorphoSys, Novartis, Sumitomo Dainippon Pharma Oncology Inc; Contracted Research: Blueprint Medicines, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Disc Medicine, Geron Corporation, Incyte Corporation, Ionis Pharmaceuticals Inc, Janssen Biotech Inc, Kartos Therapeutics, Karyopharm Therapeutics, MorphoSys, Sumitomo Dainippon Pharma Oncology Inc, Telios Pharma Inc. Dr Fleischman — Advisory Committees: CTI BioPharma, a Sobi Company, Incyte Corporation; Consulting Agreement: Ionis Pharmaceuticals Inc; Speakers Bureaus: CTI BioPharma, a Sobi Company, GSK, PharmaEssentia. Dr Yacoub — Consulting Agreements: AbbVie Inc, Acceleron Pharma, Apellis, CTI BioPharma, a Sobi Company, Gilead Sciences Inc, Incyte Corporation, Karyopharm Therapeutics, Notable Labs, Novartis, Pfizer Inc, PharmaEssentia, Protagonist Therapeutics, Servier Pharmaceuticals LLC. MODERATOR — Dr Kuykendall — Advisory Committees: AbbVie Inc, Blueprint Medicines, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Incyte Corporation, Karyopharm Therapeutics, PharmaEssentia; Consulting Agreements: AbbVie Inc, Karyopharm Therapeutics, MorphoSys; Contracted Research: Blueprint Medicines, Bristol Myers Squibb, Geron Corporation, Janssen Biotech Inc, Protagonist Therapeutics, MorphoSys; Data and Safety Monitoring Board/Committee: Geron Corporation. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from CTI BioPharma, a Sobi Company, Geron Corporation, GSK, Incyte Corporation, and Karyopharm Therapeutics. Manchester Grand Hyatt San Diego
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of myelofibrosis.
There is no fee to participate in this hybrid event. In order to attend the in-person symposium in San Diego, you must also be registered to attend the ASH 2024 Annual Meeting. Preregistration (below) is required as seating is limited for this program. IN-PERSON Registration for clinicians in practice/healthcare professionals
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. IN-PERSON Registrationfor clinicians » IN-PERSON Registration for other/industry professionals*
Please note, a limited number of seats are available to other/industry professionals on a first come, first served basis. IN-PERSON Registrationfor nonclinicians »
* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
LIVE WEBCAST Registration for all professionals
Please note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 15 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. |